Perfil
Valerie Salentey is currently the Director of Regulatory Affairs & Quality Assurance at Sensorion SA since 2020.
Prior to this, she worked as the Head of Regulatory Affairs at Neovacs SA from 2018 to 2020, Head of Regulatory Affairs at PPD France SAS in 2018, and Head of Regulatory Affairs at Genethon from 2016 to 2018.
She also worked as the Head of Regulatory Affairs at Cytheris SA from 2008 to 2013.
Cargos activos de Valerie Salentey
| Empresas | Cargo | Inicio |
|---|---|---|
| SENSORION | Consejero General | 01/04/2020 |
Antiguos cargos conocidos de Valerie Salentey.
| Empresas | Cargo | Fin |
|---|---|---|
| NEOVACS | Consejero General | 01/03/2020 |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Consejero General | 01/10/2018 |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Consejero General | 01/01/2018 |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Consejero General | 01/08/2013 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Commercial Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
- Bolsa de valores
- Insiders
- Valerie Salentey
















